Medtech firm Agatsa raises Rs 125 mn

Share Us

676
Medtech firm Agatsa raises Rs 125 mn
11 May 2022
6 min read

News Synopsis

In a bid to expand their business, Medtech company Agatsa, in its latest round of funding, has raised Rs 125 million. The vision of the company is to revolutionize the cardiac care industry in India. In a press statement, the Medtech company said that as of now, Agatsa has established itself as the first B2C med-tech brand in India, and now they are stepping into B2B collaborations with big hospitals and telehealth companies.

The key investors in the company are medical experts Dr. Ramakant Panda, MCh, Chief Consultant for Cardiovascular Thoracic Surgery and the Vice Chairman and MD of the Asian Heart Institute, BKC, Mumbai; Dr. Tejas Patel, a renowned cardiologist and Chairman of Apex Heart Institute, Ahmedabad; Dr. Ashish Parikh, Interventional Clinical Cardiologist and Chairman of Heart and Vascular Clinic in Delaware, USA, Ahmedabad based Desai Family and Hemal Patel.

While informing their plans about the company, Co-Founders of Agatsa, Neha, and Rahul Rastogi, said “This is our fourth round of funding, and we intend to grow our footprints in international markets along with growing rapidly in domestic market aggressively with this funding. As soon as we receive our FDA we are set to fly in international markets with our most affordable ECG. We would be gearing up for our next round of funding in the next 5-6 months and this would be our Series A round.”